,,,,hummm,,, I see the drug jardiance being continually advertised on CNN lately,,,,,two selling points in the ad are; for diabetes ll and reduction in CV,,,,,,,,,,,,no numbers given on cv reduction,,,,,,it was approved in 2014,,,,,,,,,fingers crossed we blow any of these competitive drugs out of the water with our data in BoM!!
Jardiance = Empagliflozin
Empagliflozin is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.
